WO2002034233A3 - Utilisation de l'association d'un carotenoide et d'un isoflavonoide pour traiter les signes cutanes du vieillissement - Google Patents

Utilisation de l'association d'un carotenoide et d'un isoflavonoide pour traiter les signes cutanes du vieillissement Download PDF

Info

Publication number
WO2002034233A3
WO2002034233A3 PCT/FR2001/003319 FR0103319W WO0234233A3 WO 2002034233 A3 WO2002034233 A3 WO 2002034233A3 FR 0103319 W FR0103319 W FR 0103319W WO 0234233 A3 WO0234233 A3 WO 0234233A3
Authority
WO
WIPO (PCT)
Prior art keywords
association
isoflavonoid
carotenoid
ageing
cutaneous symptoms
Prior art date
Application number
PCT/FR2001/003319
Other languages
English (en)
Other versions
WO2002034233A2 (fr
Inventor
Lionel Breton
Markus Baur
Christel Liviero
Original Assignee
Oreal
Lionel Breton
Markus Baur
Christel Liviero
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Oreal, Lionel Breton, Markus Baur, Christel Liviero filed Critical Oreal
Priority to JP2002537287A priority Critical patent/JP2004512295A/ja
Priority to EP01982556A priority patent/EP1331925A2/fr
Priority to AU2002214106A priority patent/AU2002214106A1/en
Publication of WO2002034233A2 publication Critical patent/WO2002034233A2/fr
Publication of WO2002034233A3 publication Critical patent/WO2002034233A3/fr
Priority to US10/424,128 priority patent/US20040071745A1/en
Priority to US12/122,943 priority patent/US20090105330A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/31—Hydrocarbons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4973—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom
    • A61K8/498—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom having 6-membered rings or their condensed derivatives, e.g. coumarin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783—Angiosperms [Magnoliophyta]
    • A61K8/9789—Magnoliopsida [dicotyledons]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/16—Emollients or protectives, e.g. against radiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Birds (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Chemical & Material Sciences (AREA)
  • Botany (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Toxicology (AREA)
  • Cosmetics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)

Abstract

L'invention se rapporte à l'utilisation dans une composition ou pour la préparation d'une composition de l'association d'au moins un caroténoïde et d'au moins un isoflavonoïde, l'association ou la composition étant destinées à traiter les signes cutanés du vieillissement, en particulier la dégradation de la peau et/ou des muqueuses par l'inhibition de l'activité et/ou de l'expression des collagénases et par l'augmentation de la synthèse de collagène.
PCT/FR2001/003319 2000-10-26 2001-10-25 Utilisation de l'association d'un carotenoide et d'un isoflavonoide pour traiter les signes cutanes du vieillissement WO2002034233A2 (fr)

Priority Applications (5)

Application Number Priority Date Filing Date Title
JP2002537287A JP2004512295A (ja) 2000-10-26 2001-10-25 皮膚加齢の徴候を処置するための少なくとも１種のカロチノイドと少なくとも１種のイソフラボノイドの組合せ物の使用
EP01982556A EP1331925A2 (fr) 2000-10-26 2001-10-25 Utilisation de l'association d' un carotenoide et d'un isoflavonoide pour traiter les signes cutanes du vieillissement
AU2002214106A AU2002214106A1 (en) 2000-10-26 2001-10-25 Use of an association of a carotenoid and of an isoflavonoid for treating cutaneous symptoms of ageing
US10/424,128 US20040071745A1 (en) 2000-10-26 2003-04-28 Admixture of carotenoids and isoflavonoids for treating cutaneous symptoms of aging
US12/122,943 US20090105330A1 (en) 2000-10-26 2008-05-19 Admixture of carotenoids and isoflavonoids for treating cutaneous symptoms of aging

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR00/13755 2000-10-26
FR0013755A FR2815861B1 (fr) 2000-10-26 2000-10-26 Utilisation de l'association d'au moins un carotenoide et d'au moins un isoflavonoide pour traiter les signes cutanes du vieillissement

Related Child Applications (1)

Application Number Title Priority Date Filing Date
US10/424,128 Continuation US20040071745A1 (en) 2000-10-26 2003-04-28 Admixture of carotenoids and isoflavonoids for treating cutaneous symptoms of aging

Publications (2)

Publication Number Publication Date
WO2002034233A2 WO2002034233A2 (fr) 2002-05-02
WO2002034233A3 true WO2002034233A3 (fr) 2002-08-29

Family

ID=8855771

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/FR2001/003319 WO2002034233A2 (fr) 2000-10-26 2001-10-25 Utilisation de l'association d'un carotenoide et d'un isoflavonoide pour traiter les signes cutanes du vieillissement

Country Status (6)

Country Link
US (2) US20040071745A1 (fr)
EP (1) EP1331925A2 (fr)
JP (2) JP2004512295A (fr)
AU (1) AU2002214106A1 (fr)
FR (1) FR2815861B1 (fr)
WO (1) WO2002034233A2 (fr)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10139792A1 (de) * 2001-08-14 2003-02-27 Beiersdorf Ag Verwendung von Tectorigenin zur Herstellung kosmetischer oder dermatologischer Zubereitungen zur Prophylaxe und Behandlung von entzündlichen Hautzuständen und/oder zum Hautschutz bei empfindlich determinierter und trockener Haut
DE10301631A1 (de) * 2003-01-17 2004-07-29 Beiersdorf Ag Kosmetische und dermatologische Zubereitungen mit einem Gehalt an Sojabohnenkeimextrakten in Kombination mit Vitamin C und/oder E sowie alpha-Glycosylrutin
FR2854897B1 (fr) * 2003-05-12 2007-05-04 Sederma Sa Compositions cosmetiques ou dermopharmaceutiques pour reduire les signes du vieillissement cutane.
DE10356864A1 (de) * 2003-12-03 2005-07-07 Beiersdorf Ag Kosmetische und dermatologische Zubereitungen mit einem Gehalt an Licochalcon A und Sojabohnenkeimextrakten
KR100739531B1 (ko) * 2004-05-07 2007-07-13 주식회사 이오텍 리코펜과 피토에스트로겐을 포함하는 혼합 조성물
EA015246B1 (ru) 2006-02-21 2011-06-30 Мэри Кэй, Инк. Неводная композиция стабильной аскорбиновой кислоты и способ ее приготовления
EP1958611A1 (fr) * 2006-12-20 2008-08-20 DSMIP Assets B.V. Composition orale contenant du EGCG et du lycopène
US20090162306A1 (en) * 2007-12-21 2009-06-25 Conopco, Inc., D/B/A Unilever Topical composition comprising coloring antioxidants
FR2944437B1 (fr) * 2009-04-16 2013-05-10 Oreal Utilisation d'inhibiteurs de l'expression d'hif 1 alpha pour proteger la peau des dommages deleteres induits par le rayonnement uva
FR2974296B1 (fr) 2011-04-19 2013-05-24 Inneov Lab Utilisation d'une combinaison d'un carotenoide, d'un phytoestrogene et de la vitamine c en tant qu'actif pour l'hydratation de la peau
FR2974300B1 (fr) 2011-04-19 2013-05-10 Inneov Lab Utilisation d'une combinaison d'un carotenoide, d'un phytoestrogene et de la vitamine c pour la prevention et/ou le traitement de desordres pigmentaires
JP2013126965A (ja) * 2011-11-14 2013-06-27 Fujifilm Corp 正常皮膚細胞用Ｎｒｆ２活性化剤
FR2996135A1 (fr) 2012-09-28 2014-04-04 Inneov Lab Composition orale pour renforcer la tolerance cutanee suite a une administration topique d'un compose retinoide.
JP6426902B2 (ja) * 2014-03-20 2018-11-21 株式会社コーセー カロテノイド含有組成物、並びにカロテノイドの劣化抑制剤及びカロテノイドの劣化抑制方法
IT201700114744A1 (it) * 2017-10-11 2019-04-11 Cristina Chiuso Formulazione polifenolica per la protezione di pelle e capelli
KR102322836B1 (ko) * 2018-12-14 2021-11-10 경희대학교 산학협력단 텍토리게닌을 유효성분으로 포함하는 피부 노화 또는 피부 주름 개선용 조성물

Citations (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH05320036A (ja) * 1992-05-19 1993-12-03 Shiseido Co Ltd 一重項酸素除去組成物
US5824702A (en) * 1996-06-07 1998-10-20 Mount Sinai School Of Medicine Of The City University Of New York Genistein as a preventive against ultraviolet induced skin photodamage and cancer
WO1998056373A1 (fr) * 1997-06-11 1998-12-17 Gorbach Sherwood L Isoflavonoïde utilise pour traiter et prevenir le vieillissement de la peau et les rides
US5904924A (en) * 1997-11-04 1999-05-18 Oncologics, Inc. Green nutritional powder composition
WO1999036050A1 (fr) * 1997-12-24 1999-07-22 Novogen Research Pty. Ltd. Compositions et procede pour la protection de la peau contre une immuno-suppression ou des lesions provoquees par les rayons uv
WO1999047118A1 (fr) * 1998-03-16 1999-09-23 The Procter & Gamble Company Compositions pour modifier l'aspect exterieur de la peau
WO1999048386A1 (fr) * 1998-03-24 1999-09-30 Stueckler Franz Produit a base de substances naturelles
FR2782919A1 (fr) * 1998-09-04 2000-03-10 Roc Sa Composition contre le vieillissement et son utilisation
WO2001037781A2 (fr) * 1999-10-28 2001-05-31 Ingredient Innovations International Dispersion aqueuse stable d'elements nutritifs

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5567454A (en) * 1994-07-13 1996-10-22 Bogdan; Jeffrey A. Nut butter and jelly food slice
DE4444238A1 (de) * 1994-12-13 1996-06-20 Beiersdorf Ag Kosmetische oder dermatologische Wirkstoffkombinationen aus Zimtsäurederivaten und Flavonglycosiden
TWI234467B (en) * 1997-06-04 2005-06-21 Univ Michigan Composition for inhibiting photoaging of skin
FR2772609B1 (fr) * 1997-12-19 2004-05-07 Oreal Utilisation d'au moins une auxine dans une composition cosmetique
US5972993A (en) * 1998-03-20 1999-10-26 Avon Products, Inc. Composition and method for treating rosacea and sensitive skin with free radical scavengers
US6150399A (en) * 1998-06-30 2000-11-21 Abbott Laboratories Soy-based nutritional products
DE19838636A1 (de) * 1998-08-26 2000-03-02 Basf Ag Carotinoid-Formulierungen, enthaltend ein Gemisch aus beta-Carotin, Lycopin und Lutein
US6630160B1 (en) * 1999-09-07 2003-10-07 Genetic Services Management, Inc. Process to modulate disease risk with doses of a nutraceutical
US20050031557A1 (en) * 1999-09-08 2005-02-10 Christine Gaertner Oral administration of beta-carotene, lycopene and lutein for human skin protection
BR0106674A (pt) * 2000-05-30 2002-04-30 Nestle Sa Composição primária que contém um composto bioativo lipofìlico

Patent Citations (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH05320036A (ja) * 1992-05-19 1993-12-03 Shiseido Co Ltd 一重項酸素除去組成物
US5824702A (en) * 1996-06-07 1998-10-20 Mount Sinai School Of Medicine Of The City University Of New York Genistein as a preventive against ultraviolet induced skin photodamage and cancer
WO1998056373A1 (fr) * 1997-06-11 1998-12-17 Gorbach Sherwood L Isoflavonoïde utilise pour traiter et prevenir le vieillissement de la peau et les rides
US5904924A (en) * 1997-11-04 1999-05-18 Oncologics, Inc. Green nutritional powder composition
WO1999036050A1 (fr) * 1997-12-24 1999-07-22 Novogen Research Pty. Ltd. Compositions et procede pour la protection de la peau contre une immuno-suppression ou des lesions provoquees par les rayons uv
WO1999047118A1 (fr) * 1998-03-16 1999-09-23 The Procter & Gamble Company Compositions pour modifier l'aspect exterieur de la peau
WO1999048386A1 (fr) * 1998-03-24 1999-09-30 Stueckler Franz Produit a base de substances naturelles
FR2782919A1 (fr) * 1998-09-04 2000-03-10 Roc Sa Composition contre le vieillissement et son utilisation
WO2001037781A2 (fr) * 1999-10-28 2001-05-31 Ingredient Innovations International Dispersion aqueuse stable d'elements nutritifs

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
DATABASE WPI Week 199402, Derwent World Patents Index; AN 1994-012180, XP002176922 *

Also Published As

Publication number Publication date
AU2002214106A1 (en) 2002-05-06
WO2002034233A2 (fr) 2002-05-02
JP2008189675A (ja) 2008-08-21
JP2004512295A (ja) 2004-04-22
US20090105330A1 (en) 2009-04-23
US20040071745A1 (en) 2004-04-15
FR2815861B1 (fr) 2003-02-28
FR2815861A1 (fr) 2002-05-03
EP1331925A2 (fr) 2003-08-06

Similar Documents

Publication Publication Date Title
WO2002034233A3 (fr) Utilisation de l'association d'un carotenoide et d'un isoflavonoide pour traiter les signes cutanes du vieillissement
AU2001282399A1 (en) Resorcinol derivatives
WO2001094381A3 (fr) Nouveaux composes de la famille des n-acylamino-amides, compositions les comprenant, et utilisations
EP1077063A3 (fr) Méthodes pour agir sur la pigmentation de la peau
AU2001253038A1 (en) Cosmetic and pharmaceutical compositions and methods using 2-decarboxy-2-phosphinico derivatives
AU3162901A (en) Reducing damage to hair during oxidative processes
WO2004031350A3 (fr) Modulation de l'expression du gene forkhead box o1a
BR0210791A (pt) Composição tendo atividade bacteristática e bactericida contra esporos bacterianos e células vegetativas e processo para tratamento de alimentos utilizando a mesma
WO2002024613A3 (fr) Derives de resorcine
AU2003291165A1 (en) Treating arrhythmias by altering properties of tissue
WO2005020877A3 (fr) Utilisation de biotine ou d'un derive de biotine pour eclaircir le teint et traiter les taches de vieillesse
WO2004000230A3 (fr) Derives de cyclothiocarbamative utilises comme modulateurs pr et leur utilisation pour traiter des troubles cutanes
MXPA02002118A (es) Composiciones que contienen productos leguminosos.
WO2002034232A3 (fr) Utilisation de carotenoides pour traiter les signes cutanes du vieillissement
PL370795A1 (en) Composition based on etyllinoleate and triethylcitrate for the treatment of seborrhea and acne
MXPA02002119A (es) Productos leguminosos.
MY121523A (en) Resorcinol derivatives
WO2002034210A3 (fr) Utilisation de l'association d'au moins un carotenoide et de vitamine c pour traiter les signes cutanes du vieillissement
IL156170A0 (en) Use of 1-phenyl-3-dimethylaminopropane compounds for treating urinary incontinence
WO2005034997A3 (fr) Utilisation de la photosensibilisation
AU2002366530A1 (en) Utilization of dihydropinosylvin and derivatives thereof as tyrosinase inhibitors for skin lightening or as antimicrobial substances for preservation or for the treatment of acne, dandruff or body odors
AP1413A (en) Rescorcinol composition.
AU6479000A (en) Novel use of prodigiosin for treating diabetes mellitus
EP1236402A3 (fr) Compositions contenant des produits de légumes
AU2002347984A1 (en) Use of norepinephrine reuptake inhibitors for the treatment of tic disorders

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
WWE Wipo information: entry into national phase

Ref document number: 2001982556

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 2002537287

Country of ref document: JP

WWP Wipo information: published in national office

Ref document number: 2001982556

Country of ref document: EP

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642